CTSA-IP

a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes.

Mike Hazard, Scott Steele, Dongwen Wang, Thomas Pearson, Mark Scheideler, Steve Dewhurst

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

One of the objectives of the Consortium of Institutions with Clinical and Translational Science Awards (CTSAs) is to enhance technology transfer among the CTSAs and with public and private sector partners. Clinical and Translational Sciences Award Intellectual Property (CTSA-IP; http://www.CTSAIP.org) is a web-based, open access IP search tool that aggregates and promotes technologies from member institutions of the National Institutes of Health's (NIH) CTSAs consortium. Its ultimate aim is to stimulate collaborative research activity by encouraging the formation of public-private partnerships with CTSA institutions and the NIH. First launched in 2009, CTSA-IP has grown rapidly and met its first objectives of developing wide member institution participation and site usage. This communication will discuss the strategy employed in the initiative of aggregating IP across institutional boundaries, the promise that lies therein, as well as the challenges encountered and lessons learned in promoting CTSA-wide engagement.

Original languageEnglish (US)
Pages (from-to)328-331
Number of pages4
JournalClinical and Translational Science
Volume4
Issue number5
StatePublished - Oct 2011
Externally publishedYes

Fingerprint

Intellectual Property
Intellectual property
National Institutes of Health (U.S.)
Biomedical Research
Health
Technology transfer
Public-Private Sector Partnerships
Technology Transfer
Private Sector
Public Sector
Communication
Technology

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

CTSA-IP : a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes. / Hazard, Mike; Steele, Scott; Wang, Dongwen; Pearson, Thomas; Scheideler, Mark; Dewhurst, Steve.

In: Clinical and Translational Science, Vol. 4, No. 5, 10.2011, p. 328-331.

Research output: Contribution to journalArticle

@article{511abe99e28b4ac19aad215b3c08258c,
title = "CTSA-IP: a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes.",
abstract = "One of the objectives of the Consortium of Institutions with Clinical and Translational Science Awards (CTSAs) is to enhance technology transfer among the CTSAs and with public and private sector partners. Clinical and Translational Sciences Award Intellectual Property (CTSA-IP; http://www.CTSAIP.org) is a web-based, open access IP search tool that aggregates and promotes technologies from member institutions of the National Institutes of Health's (NIH) CTSAs consortium. Its ultimate aim is to stimulate collaborative research activity by encouraging the formation of public-private partnerships with CTSA institutions and the NIH. First launched in 2009, CTSA-IP has grown rapidly and met its first objectives of developing wide member institution participation and site usage. This communication will discuss the strategy employed in the initiative of aggregating IP across institutional boundaries, the promise that lies therein, as well as the challenges encountered and lessons learned in promoting CTSA-wide engagement.",
author = "Mike Hazard and Scott Steele and Dongwen Wang and Thomas Pearson and Mark Scheideler and Steve Dewhurst",
year = "2011",
month = "10",
language = "English (US)",
volume = "4",
pages = "328--331",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - CTSA-IP

T2 - a solution to identifying and aggregating intellectual property across the NIH Clinical Translational Science Award (CTSA) consortium of biomedical research institutes.

AU - Hazard, Mike

AU - Steele, Scott

AU - Wang, Dongwen

AU - Pearson, Thomas

AU - Scheideler, Mark

AU - Dewhurst, Steve

PY - 2011/10

Y1 - 2011/10

N2 - One of the objectives of the Consortium of Institutions with Clinical and Translational Science Awards (CTSAs) is to enhance technology transfer among the CTSAs and with public and private sector partners. Clinical and Translational Sciences Award Intellectual Property (CTSA-IP; http://www.CTSAIP.org) is a web-based, open access IP search tool that aggregates and promotes technologies from member institutions of the National Institutes of Health's (NIH) CTSAs consortium. Its ultimate aim is to stimulate collaborative research activity by encouraging the formation of public-private partnerships with CTSA institutions and the NIH. First launched in 2009, CTSA-IP has grown rapidly and met its first objectives of developing wide member institution participation and site usage. This communication will discuss the strategy employed in the initiative of aggregating IP across institutional boundaries, the promise that lies therein, as well as the challenges encountered and lessons learned in promoting CTSA-wide engagement.

AB - One of the objectives of the Consortium of Institutions with Clinical and Translational Science Awards (CTSAs) is to enhance technology transfer among the CTSAs and with public and private sector partners. Clinical and Translational Sciences Award Intellectual Property (CTSA-IP; http://www.CTSAIP.org) is a web-based, open access IP search tool that aggregates and promotes technologies from member institutions of the National Institutes of Health's (NIH) CTSAs consortium. Its ultimate aim is to stimulate collaborative research activity by encouraging the formation of public-private partnerships with CTSA institutions and the NIH. First launched in 2009, CTSA-IP has grown rapidly and met its first objectives of developing wide member institution participation and site usage. This communication will discuss the strategy employed in the initiative of aggregating IP across institutional boundaries, the promise that lies therein, as well as the challenges encountered and lessons learned in promoting CTSA-wide engagement.

UR - http://www.scopus.com/inward/record.url?scp=84862833116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862833116&partnerID=8YFLogxK

M3 - Article

VL - 4

SP - 328

EP - 331

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 5

ER -